发明名称 CD44 BINDING PEPTIDES
摘要 The present invention relates to a protein which binds to the domain encoded by exon 9 of human CD44 (CD44ex9), to fusion proteins and conjugates of said protein and especially to nanoparticles conjugated to said protein. The invention further relates to a method of production for the protein and the respective conjugated nanoparticles and the use of the protein of the invention for treatment and diagnosis of cancer diseases.
申请公布号 US2017073392(A1) 申请公布日期 2017.03.16
申请号 US201415107790 申请日期 2014.12.22
申请人 ARNTZ CLAUDIA;GREB WOLFGANG 发明人 ARNTZ CLAUDIA;GREB WOLFGANG
分类号 C07K14/705;G01N33/574;A61K47/48;G01N33/58;A61K49/00 主分类号 C07K14/705
代理机构 代理人
主权项 1. A protein binding to a polypeptide encoded by exon 9 of human CD44 (CD44ex9), said protein comprises or consists of (i) an amino acid sequence according SEQ ID No. 1 to 5 and SEQ ID No. 39 to 52; or (ii) an amino acid sequence with at least 90% identity to the amino acid sequence given in SEQ ID No. 1 to 5 and SEQ ID No. 39 to 52; or (iii) an amino acid sequence with 100% identity to the CD44-binding motif defined by the sequence: “PYYGKXLX3YLQPSFAVQVX2SXQX10-14AIE” as depicted in SEQ ID Nos. 6 to 10 or defined by the sequence: “PGLQPSFAVQVX2S/AXQX10-14AIE” as depicted in SEQ ID Nos. 53 to 62, wherein X denotes an arbitrary amino acid; and wherein said protein has a length of 100 amino acids or less.
地址 LENGERICH DE